James Haim I. Bicher (born May 12, 1937) is an American radiation oncologist. He was born in San Cristóbal, Santa Fe, Argentina and is a pioneer in the clinical use of hyperthermia combined with low dose (protracted) radiation therapy (thermoradiotherapy). He is a founder and past president of ISOTT, , and the American Society of Clinical Hyperthermic Oncology. Bicher was a student of Bernardo Alberto Houssay, and one of the contributors to the basic principles that allowed later development of Plavix.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - James Haim I. Bicher (en)
|
rdfs:comment
| - James Haim I. Bicher (born May 12, 1937) is an American radiation oncologist. He was born in San Cristóbal, Santa Fe, Argentina and is a pioneer in the clinical use of hyperthermia combined with low dose (protracted) radiation therapy (thermoradiotherapy). He is a founder and past president of ISOTT, , and the American Society of Clinical Hyperthermic Oncology. Bicher was a student of Bernardo Alberto Houssay, and one of the contributors to the basic principles that allowed later development of Plavix. (en)
|
foaf:name
| - James Haim I. Bicher (en)
|
name
| - James Haim I. Bicher (en)
|
foaf:depiction
| |
birth place
| |
birth place
| - San Cristóbal, Santa Fe, Argentina (en)
|
birth date
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
specialism
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
birth date
| |
profession
| - Radiation oncologist (en)
|
has abstract
| - James Haim I. Bicher (born May 12, 1937) is an American radiation oncologist. He was born in San Cristóbal, Santa Fe, Argentina and is a pioneer in the clinical use of hyperthermia combined with low dose (protracted) radiation therapy (thermoradiotherapy). He is a founder and past president of ISOTT, , and the American Society of Clinical Hyperthermic Oncology. Bicher was a student of Bernardo Alberto Houssay, and one of the contributors to the basic principles that allowed later development of Plavix. (en)
|
gold:hypernym
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is foaf:primaryTopic
of | |